Who Paid My Doc
Cephea Early Feasibility Study
Research payments
$412,409
Through program year 2023, $412,409 in research payments was reported against Cephea Early Feasibility Study, across 68 payments, paid by Abbott Laboratories.
- Paid by
- Abbott Laboratories
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $15,910 | 7 |
| 2022 | Research | $396,499 | 61 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mario Goessl Minneapolis, MN Named on 12 payments
- Vinod Thourani Marietta, GA Named on 11 payments
- Michael Rinaldi Charlotte, NC Named on 8 payments
- Gorav Ailawadi Ann Arbor, MI Named on 8 payments
- Bassem Chehab Wichita, KS Named on 7 payments
- Jason Rogers Sacramento, CA Named on 6 payments
- Rajendra Makkar West Hollywood, CA Named on 5 payments
- Sachin Goel Houston, TX Named on 3 payments
- Samir Kapadia Cleveland, OH Named on 3 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.